Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study.
Juhan-Vague
I
I
Morange
P E
PE
D000941:Antigens / Q000096:biosynthesis*; D025901:Carboxypeptidase B2 / Q000096:biosynthesis*; D002268:Carboxypeptidases / Q000096:biosynthesis; D016022:Case-Control Studies; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis; D012306:Risk
D000941:Antigens; D002268:Carboxypeptidases; D025901:Carboxypeptidase B2